Insurance Delays and Denials Create Barriers to Advanced Cancer Treatment

Proton therapy, a proven and life-saving cancer treatment, remains inaccessible to many patients whose physicians have recommended it for certain types of cancer. Restrictive insurance guidelines and a burdensome prior authorization process create barriers for cancer patients and often lead to negative patient outcomes. The lack of insurance coverage limits the number of patients participating in clinical trials, hindering the ability to generate further evidence supporting the value of proton therapy.